N-METHYL-2-(4-NITRO-1H-PYRAZOL-1-YL)ACETAMIDE, 95.0%, 10g

3-Chloro-4-methylsulfonylaniline, 95.0%, 250mg

3-Bromo-6-(trifluoromethyl)pyridazine, 97%, 5g

3-Amino-N-methylisonicotinamide, 97%, 1g

1-Bromo-2,3-dimethyl-4-(phenylmethoxy)benzene, 95+%, 5g

1-(5-Methyloxazol-2-yl)propan-2-one, 98%, 100mg

Probenröhrchen, verjüngter Rundboden, 12 ml, PS, 18 x 105 mm, rund, Achtung, Artikel zukünftig ohne CE/IVD-Kennzeichnung, 1500 Stück

1-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]ethanamine, 95.0%, 1g

[(1S,9aR)-octahydro-2H-quinolizin-1-ylmethyl]amine dihydrochloride, 95.0%, 1g

5-chloro-3-(pentylsulfanyl)-1,2,4-thiadiazole, 95.0%, 1g

n-Cyclohexyl-1,3-benzothiazol-2-amine, 98%, 10g

4-(METHYLTHIO)-2-(2-PHENOXYPHENYL)PYRIDO[3,4-D]PYRIMIDINE, 95.0%, 250mg

4-Amino-2-chloro-3-nitropyridine>97.0%(GC)(T)200mg